Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Segment Results
ELV logo

Elevance Health Revenues Surge 12% to $50B Amid Rising Medical Costs

ELV10-QFiling Date: 10/21/2025
Elevance Health, Inc.
Description

What this story covers

Elevance Health's Q3 2025 10-Q shows 12% revenue growth to $50.1B, driven by premium increases. Net income rose quarterly, but nine-month EPS dipped due to investment losses. Segments face pressure from Medicaid shifts, while pharmacy and services expand. Strong liquidity funds buybacks and acquisitions. (40 words)

Story snapshot

CompanyElevance Health, Inc.
TickerELV
VariantStandard detailed
Duration14:33
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001156039-25-000136

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in